InflaRx NV (IFRX)
2.245
+0.12
(+5.40%)
USD |
NASDAQ |
Dec 20, 16:00
2.24
0.00 (0.00%)
After-Hours: 20:00
InflaRx Profit Margin (Quarterly): -14.09K% for Sept. 30, 2024
Profit Margin (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Profit Margin (Quarterly) Benchmarks
| Affimed NV | -9.77K% |
| BioNTech SE | 15.91% |
| Immatics NV | -16.95% |
| CureVac NV | 68.44% |
| ATAI Life Sciences NV | -65.72K% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -61.55% |
| Return on Assets | -53.75% |
| Return on Invested Capital | -61.55% |
| Operating Margin (Quarterly) | -12.41K% |
| Return on Net Operating Assets | -227.6% |